PMID23105685
:
A comparative study on the effects of diet and exercise, metformin and metformin+pioglitazone treatment on NIDDM patients.
Abstract
A comparative study on two groups of newly diagnosed nonobese and obese NIDDM patients who were 15 in each group and treated by diet cum exercise and metfromin monotherapy respectively and a third group of 15 obese NIDDM patients whose hyperglycemia was not first controlled by a combination therapy of metformin and sulfonylurea and therefore changed over to a different combination therapy of metformin and ploglitazone, was carried out before and after a period of three months treatment. The mild hyperglycemia in the 1(st) group and the moderate or severe hyperglycemia with accompanied disorders of serum enzymes such as AST, ALT, GGT and the level of HBA(10) observed with 2(nd) and 3(rd) groups of obese NIDDM patients were significantly ameliorated by the respective mode of treatments. Here the efficacies of the three types of treatment are substantiated and further it specifically depicts the success with the choice of combination therapy with metformin and pioglitazone in the third group of obese diabetics.
Structured Findings
Metformin and ploglitazone
significantly decreased
HBA(10)
compared to
Diet cum exercise and metformin monotherapy
Structured Markup
Intervention |
Comparator |
Outcome |
Label |
Metformin and ploglitazone |
Diet cum exercise and metformin monotherapy |
HBA(10) |
significantly decreased |